MHRA business engagement assessment - variations processing review
Read the full outcome
Detail of outcome
MHRA sought views on a new process to coordinate assessment and processing of applications to change (vary) a medicines marketing authorisation called Composite Coordination Collection (CCC).
The agency asked the pharmaceutical industry to comment on any aspect of the business engagement assessment, particularly with a view to quantify costs and benefits of the proposal.
Original consultation
Consultation description
MHRA is seeking views on a new process to coordinate assessment and processing of applications to change (vary) a medicines marketing authorisation called Composite Coordination Collection (CCC).
The agency would like the pharmaceutical industry to comment on any aspect of this business engagement assessment, particularly with a view to quantify costs and benefits of the proposal.
The deadline for comments is 30 January 2014 and a final business engagement assessment will be published shortly after.
Please send comments to stephen.fawbert@mhra.gov.uk.